ID

14822

Description

Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL; ODM derived from: https://clinicaltrials.gov/show/NCT01562977

Lien

https://clinicaltrials.gov/show/NCT01562977

Mots-clés

  1. 29/04/2016 29/04/2016 -
Téléchargé le

29 avril 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :


Aucun commentaire

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Aggressive Lymphoma NCT01562977

Eligibility Aggressive Lymphoma NCT01562977

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age ≥ 18 years.
Description

age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
dlbcl and mcl diagnosed patients in primary resistance or relapsed not eligible for intensification chemotherapy followed by autologous stem cell transplantation (asct) for age, comorbidity or previous asct.
Description

Diffuse Large B-Cell Lymphoma

Type de données

boolean

Alias
UMLS CUI [1]
C0079744
any ipi or ecog, capable of understanding the nature of the trial.
Description

ecog

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
writtern informed consent.
Description

informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
nursing pregnant or lactation period women, or fertile age adults not using effective contraceptive method.
Description

pregnant or lactation women

Type de données

boolean

Alias
UMLS CUI [1,1]
C2828358
UMLS CUI [1,2]
C0549206
cns lymphoma patients
Description

Central nervous system lymphoma

Type de données

boolean

Alias
UMLS CUI [1]
C0742472
patients with severa renal (creatinine> 2,5 unl) or hepatic (bilirrubin or alt/ast> 2,5 unl) impairement not provided by the same disease
Description

renal or hepatic impairement

Type de données

boolean

Alias
UMLS CUI [1]
C0948807
UMLS CUI [2]
C0948807
hiv positive patients.
Description

hiv positive

Type de données

boolean

Alias
UMLS CUI [1]
C0019699
serious psychiatric diseases patients that could interfere with their skill to understand the study (including alcoholism or drug addiction).
Description

psychiatric disease

Type de données

boolean

Alias
UMLS CUI [1]
C0004936
murine proteins or any other component of the medicines of the study hypersensitivity patients.
Description

murine protein

Type de données

boolean

Alias
UMLS CUI [1]
C1699668
patients who have received more than 2 therapeutic previous lines. (for previous asct patients, induction and conditioning for the taph treatment is considered a single line therapy).
Description

patients who have received more than 2 therapeutic previous lines

Type de données

boolean

Alias
UMLS CUI [1]
C0868551

Similar models

Eligibility Aggressive Lymphoma NCT01562977

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
age ≥ 18 years.
boolean
C0001779 (UMLS CUI [1])
Diffuse Large B-Cell Lymphoma
Item
dlbcl and mcl diagnosed patients in primary resistance or relapsed not eligible for intensification chemotherapy followed by autologous stem cell transplantation (asct) for age, comorbidity or previous asct.
boolean
C0079744 (UMLS CUI [1])
ecog
Item
any ipi or ecog, capable of understanding the nature of the trial.
boolean
C1520224 (UMLS CUI [1])
informed consent
Item
writtern informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pregnant or lactation women
Item
nursing pregnant or lactation period women, or fertile age adults not using effective contraceptive method.
boolean
C2828358 (UMLS CUI [1,1])
C0549206 (UMLS CUI [1,2])
Central nervous system lymphoma
Item
cns lymphoma patients
boolean
C0742472 (UMLS CUI [1])
renal or hepatic impairement
Item
patients with severa renal (creatinine> 2,5 unl) or hepatic (bilirrubin or alt/ast> 2,5 unl) impairement not provided by the same disease
boolean
C0948807 (UMLS CUI [1])
C0948807 (UMLS CUI [2])
hiv positive
Item
hiv positive patients.
boolean
C0019699 (UMLS CUI [1])
psychiatric disease
Item
serious psychiatric diseases patients that could interfere with their skill to understand the study (including alcoholism or drug addiction).
boolean
C0004936 (UMLS CUI [1])
murine protein
Item
murine proteins or any other component of the medicines of the study hypersensitivity patients.
boolean
C1699668 (UMLS CUI [1])
patients who have received more than 2 therapeutic previous lines
Item
patients who have received more than 2 therapeutic previous lines. (for previous asct patients, induction and conditioning for the taph treatment is considered a single line therapy).
boolean
C0868551 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial